Controversial prostate cancer screening can be improved by repeating abnormal tests

For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned because it leads to many unnecessary biopsies. Now, a new study shows that simply repeating abnormal PSA tests dramatically reduces unnecessary biopsies.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1lZcirp